Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: a corollary from the CLAMORS study

Schizophr Res. 2008 Feb;99(1-3):23-8. doi: 10.1016/j.schres.2007.10.015. Epub 2007 Dec 11.

Abstract

Objective: To analyze the concordance between standard and modified NCEP-ATP-III criteria for identification of metabolic syndrome (MS) in outpatients with schizophrenia.

Method: We used the sample from a cross-sectional study carried out to ascertain the prevalence of MS in schizophrenia. Kappa agreement and the symmetry Kendall's tau-b coefficients were calculated in a post-hoc analysis, a long with McNemar test and logistic regression models.

Results: The study enrolled 1,452 consecutive outpatients. MS was found in 24.6% (95%CI: 22.4%-26.8%) using the standard criteria and in 25.5% (23.2%-27.7%) using the modified criteria. Agreement was high; kappa 0.81 (p<0.0001) and tau-b 0.81 (p<0.0001), with a McNemar value of 0.2325. Kappa coefficients varied between 1.0 and 0.76 in subgroups according to sex, age-group, severity of disease, and duration of therapy.

Conclusions: MS in outpatients with schizophrenia may be assessed by either the standard or the modified NCEP ATP III criteria without losing reliability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Ambulatory Care
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Body Height
  • Body Mass Index
  • Body Weight / drug effects
  • Comorbidity
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertriglyceridemia / chemically induced
  • Hypertriglyceridemia / diagnosis
  • Hypertriglyceridemia / epidemiology
  • Logistic Models
  • Male
  • Metabolic Syndrome / chemically induced*
  • Metabolic Syndrome / diagnosis*
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Practice Guidelines as Topic
  • Psychotic Disorders / diagnosis
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / epidemiology
  • Reproducibility of Results
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*
  • Schizophrenia / epidemiology
  • Spain
  • Waist-Hip Ratio

Substances

  • Antipsychotic Agents